Eren Ersoy1, Hakan Akbulut, Gökhan Moray. 1. Department of General Surgery, Ankara Atatürk Research and Education Hospital, Acar Beytepe Evleri No: 154/27, Beytepe, Ankara, Turkey.
Abstract
PURPOSE: Oxaliplatin (OX) and 5-fluorouracil (5-FU) are the most widely used chemotherapeutic agents in the adjuvant treatment of colon cancer. Although the early initiation of adjuvant chemotherapy can improve the outcome of surgery, it carries potentially fatal risks. This experimental study investigates the effects of 5-FU and OX on colon anastomoses. METHODS: We used 60 rats, divided into six groups. After being subjected to bowel resection and anastomosis, the rats were given 5-FU on days 1-3, or OX 130 mg/m(2) on days 1 or 5, or 5% dextrose as a control. The bursting pressures and hydroxyproline content of the anastomoses were measured, and complications and adhesions were recorded. RESULTS: There were no major complications in the treatment groups. The bursting pressures of the 5-FU group were significantly lower than those of the control and OX groups. The bursting pressures of the OX groups were not significantly different from those of the control groups. The hydroxyproline levels of the rats treated with OX on day 1 were significantly lower than those of the rats treated with OX on day 5 and the 5-FU groups. CONCLUSION: Oxaliplatin and 5-FU did not compromise wound healing of the colon significantly. Our results indicate that OX is less detrimental to the healing of colonic anastomoses, when administered on days 1 and 5 after resection, than 5-FU.
PURPOSE:Oxaliplatin (OX) and 5-fluorouracil (5-FU) are the most widely used chemotherapeutic agents in the adjuvant treatment of colon cancer. Although the early initiation of adjuvant chemotherapy can improve the outcome of surgery, it carries potentially fatal risks. This experimental study investigates the effects of 5-FU and OX on colon anastomoses. METHODS: We used 60 rats, divided into six groups. After being subjected to bowel resection and anastomosis, the rats were given 5-FU on days 1-3, or OX 130 mg/m(2) on days 1 or 5, or 5% dextrose as a control. The bursting pressures and hydroxyproline content of the anastomoses were measured, and complications and adhesions were recorded. RESULTS: There were no major complications in the treatment groups. The bursting pressures of the 5-FU group were significantly lower than those of the control and OX groups. The bursting pressures of the OX groups were not significantly different from those of the control groups. The hydroxyproline levels of the rats treated with OX on day 1 were significantly lower than those of the rats treated with OX on day 5 and the 5-FU groups. CONCLUSION:Oxaliplatin and 5-FU did not compromise wound healing of the colon significantly. Our results indicate that OX is less detrimental to the healing of colonic anastomoses, when administered on days 1 and 5 after resection, than 5-FU.
Authors: A Sobrero; D Kerr; B Glimelius; E Van Cutsem; G Milano; D M Pritchard; P Rougier; M Aapro Journal: Eur J Cancer Date: 2000-03 Impact factor: 9.162
Authors: Ramazan Yildiz; Mehmet Fatih Can; Gokhan Yagci; Taner Ozgurtas; Metin Guden; Mehmet Gamsizkan; Erkan Ozturk; Sadettin Cetiner Journal: Int Surg Date: 2013 Jan-Mar
Authors: Cebrail Akyuz; Necdet Fatih Yasar; Orhan Uzun; Kıvanc Derya Peker; Oguzhan Sunamak; Mustafa Duman; Ahmet Ozer Sehirli; Sinan Yol Journal: Singapore Med J Date: 2018-03-19 Impact factor: 1.858
Authors: Claire M Payne; Cheray Crowley-Skillicorn; Hana Holubec; Katerina Dvorak; Carol Bernstein; Mary Pat Moyer; Harinder Garewal; Harris Bernstein Journal: J Toxicol Date: 2009-05-10